W.F. Owen
Department of Medicine
Brigham & Women's Hospital Harvard Medical School
Boston
Massachusetts
USA
Name/email consistency: high
- Beta 2-microglobulin modified with advanced glycation end products modulates collagen synthesis by human fibroblasts. Owen, W.F., Hou, F.F., Stuart, R.O., Kay, J., Boyce, J., Chertow, G.M., Schmidt, A.M. Kidney Int. (1998)
- C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Owen, W.F., Lowrie, E.G. Kidney Int. (1998)
- Dose of hemodialysis and survival: differences by race and sex. Owen, W.F., Chertow, G.M., Lazarus, J.M., Lowrie, E.G. JAMA (1998)
- Status of hemodialysis adequacy in the United States: does it account for improved patient survival?. Owen, W.F. Am. J. Kidney Dis. (1998)